HUT67006A - Buffered composition containing mammalian superoxide-dismutase/polyethylene glycol coniugate - Google Patents
Buffered composition containing mammalian superoxide-dismutase/polyethylene glycol coniugate Download PDFInfo
- Publication number
- HUT67006A HUT67006A HU9400328A HU9400328A HUT67006A HU T67006 A HUT67006 A HU T67006A HU 9400328 A HU9400328 A HU 9400328A HU 9400328 A HU9400328 A HU 9400328A HU T67006 A HUT67006 A HU T67006A
- Authority
- HU
- Hungary
- Prior art keywords
- peg
- buffer
- msod
- composition
- sod
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74025591A | 1991-08-05 | 1991-08-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9400328D0 HU9400328D0 (en) | 1994-05-30 |
HUT67006A true HUT67006A (en) | 1995-01-30 |
Family
ID=24975708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9400328A HUT67006A (en) | 1991-08-05 | 1992-08-04 | Buffered composition containing mammalian superoxide-dismutase/polyethylene glycol coniugate |
Country Status (7)
Country | Link |
---|---|
EP (2) | EP0598037A1 (es) |
JP (1) | JPH06509582A (es) |
AU (1) | AU666325B2 (es) |
CA (1) | CA2114240A1 (es) |
HU (1) | HUT67006A (es) |
MX (1) | MX9204545A (es) |
WO (1) | WO1993002701A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2101361A1 (en) * | 1992-08-27 | 1994-02-28 | Robert A. Snow | Low diol polyalkylene oxide biologically active proteinaceous substances |
GB0503337D0 (en) | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH084504B2 (ja) * | 1985-04-26 | 1996-01-24 | 味の素株式会社 | 安定化ス−パ−オキサイドジスムタ−ゼ |
IE64284B1 (en) * | 1987-08-03 | 1995-07-26 | Ddi Pharmaceuticals | Conjugates of superoxide dismutase |
JPH0610138B2 (ja) * | 1988-07-12 | 1994-02-09 | 日本化薬株式会社 | スーパーオキシドディスムターゼ組成物 |
EP0424033A3 (en) * | 1989-10-19 | 1991-07-31 | Pola Chemical Industries Inc | External skin preparation |
-
1992
- 1992-08-04 EP EP92917825A patent/EP0598037A1/en not_active Withdrawn
- 1992-08-04 HU HU9400328A patent/HUT67006A/hu unknown
- 1992-08-04 AU AU24306/92A patent/AU666325B2/en not_active Ceased
- 1992-08-04 EP EP92202423A patent/EP0535723A1/en not_active Withdrawn
- 1992-08-04 JP JP5503783A patent/JPH06509582A/ja active Pending
- 1992-08-04 CA CA002114240A patent/CA2114240A1/en not_active Abandoned
- 1992-08-04 WO PCT/US1992/006433 patent/WO1993002701A1/en not_active Application Discontinuation
- 1992-08-05 MX MX9204545A patent/MX9204545A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX9204545A (es) | 1993-02-01 |
JPH06509582A (ja) | 1994-10-27 |
HU9400328D0 (en) | 1994-05-30 |
EP0598037A1 (en) | 1994-05-25 |
AU2430692A (en) | 1993-03-02 |
EP0535723A1 (en) | 1993-04-07 |
WO1993002701A1 (en) | 1993-02-18 |
AU666325B2 (en) | 1996-02-08 |
CA2114240A1 (en) | 1993-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5334382A (en) | Lyophilized polyethylene oxide modified catalase composition, polypeptide complexes with cyclodextrin and treatment of diseases with the catalase compositions | |
US5981485A (en) | Human growth hormone aqueous formulation | |
US5283317A (en) | Intermediates for conjugation of polypeptides with high molecular weight polyalkylene glycols | |
RU2281954C2 (ru) | Очищенный препарат уриказы млекопитающего, способ его получения, препарат активного уриказного конъюгата и фармацевтический состав | |
CA2139358C (en) | Human growth hormone aqueous formulation | |
US6165509A (en) | Pegylated drug complexed with bioadhesive polymer suitable for drug delivery and methods relating thereto | |
JP2022037215A (ja) | 凍結乾燥した組換え型vwf製剤 | |
KR101752508B1 (ko) | 제8 인자 제형 | |
TW570981B (en) | PEG-urate oxidase conjugates and use thereof | |
CZ287626B6 (en) | Interferon aqueous solution | |
CA1309046C (en) | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols | |
KR100700963B1 (ko) | 켐토테신의 다당체 유도체를 함유하는 동결건조된 액상제제 | |
US20150329519A1 (en) | Formulations Comprising Lipoyl Compounds | |
JP4887281B2 (ja) | 液体エリスロポエチン製剤 | |
HUT67006A (en) | Buffered composition containing mammalian superoxide-dismutase/polyethylene glycol coniugate | |
JPH05508640A (ja) | 線維芽細胞成長因子を含む安定な医薬組成物 | |
Zanma et al. | Conjugates of superoxide dismutase with the Fc fragment of immunoglobulin G | |
Mao et al. | Superoxide dismutase: improving its pharmacological properties by conjugation with human serum albumin | |
EP0419251B1 (en) | Protein-containing aqueous solutions | |
WO1988004925A1 (en) | Protection against aminoglycoside-induced nephrotoxicity | |
US20090029911A1 (en) | Liquid Human Growth Hormone Formulation Containing Polyethylene Glycol | |
AU597955B2 (en) | Stable injectable antiemetic compositions | |
KR100534622B1 (ko) | 에리트로포이에틴과 인간 혈청알부민의 포합체 | |
WO2020086937A1 (en) | Engineered primate cystine/cysteine degrading enzymes for therapeutic uses | |
JPH1112194A (ja) | 組織プラスミノーゲン活性化因子医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DGB9 | Succession in title of applicant |
Owner name: SANOFI, FR |
|
DFC4 | Cancellation of temporary prot. due to refusal |